Bernard Têtu

52.2k total citations · 1 hit paper
196 papers, 8.4k citations indexed

About

Bernard Têtu is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bernard Têtu has authored 196 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Oncology, 54 papers in Molecular Biology and 54 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bernard Têtu's work include Prostate Cancer Treatment and Research (32 papers), Prostate Cancer Diagnosis and Treatment (25 papers) and Ovarian cancer diagnosis and treatment (22 papers). Bernard Têtu is often cited by papers focused on Prostate Cancer Treatment and Research (32 papers), Prostate Cancer Diagnosis and Treatment (25 papers) and Ovarian cancer diagnosis and treatment (22 papers). Bernard Têtu collaborates with scholars based in Canada, United States and Netherlands. Bernard Têtu's co-authors include Yves Fradet, Marie Plante, Jacques Brisson, Isabelle Bairati, A. Fortin, Alberto G. Ayala, François Meyer, François Harel, Jae Y. Ro and Nelson G. Ordóǹez and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Bernard Têtu

196 papers receiving 8.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Molecular Basis of Turcot's Syndrome

1995 719 citations Stanley R. Hamilton, Bo Liu et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Bernard Têtu

Since Specialization

Citations

This map shows the geographic impact of Bernard Têtu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Têtu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Têtu more than expected).

Fields of papers citing papers by Bernard Têtu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Têtu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Têtu. The network helps show where Bernard Têtu may publish in the future.

Co-authorship network of co-authors of Bernard Têtu

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Têtu. A scholar is included among the top collaborators of Bernard Têtu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Têtu. Bernard Têtu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of Abundant and Functional dodecaRNAs (doRNAs) Derived from Ribosomal RNA 2021 ·International Journal of Molecular Sciences ·(unknown), Abderrahim Benmoussa, (unknown), (unknown), Véronique Dorval, Nathalie Majeau, Charles Joly-Beauparlant, Arnaud Droit, Alain Bergeron, Bernard Têtu, Yves Fradet, Frédéric Pouliot, Patrick Provost	7
2	Prostatic and Dietary Omega-3 Fatty Acids and Prostate Cancer Progression during Active Surveillance 2014 ·Cancer Prevention Research ·(unknown), Janie Allaire, Caroline Léger, (unknown), Marie‐Ève Labonté, Benoı̂t Lamarche, Pierre Julien, Patrice Desmeules, Bernard Têtu, Vincent Fradet	30
3	A 2-Stage, Single-Arm, Phase 2 Study of Epigallocatechin Gallate–Enriched Green Tea Drink as a Maintenance Therapy in Women With Advanced-Stage Ovarian Cancer 2014 ·Obstetrical & Gynecological Survey ·Dominique Trudel, David P. Labbé, Monica Araya-Farias, Alain Doyen, Laurent Bazinet, Thierry Duchesne, Marie Plante, Jean‐Pierre Grégoire, Marie‐Claude Renaud, Dimcho Bachvarov, Bernard Têtu, Isabelle Bairati	1
4	Importance of 5α-Reductase Gene Polymorphisms on Circulating and Intraprostatic Androgens in Prostate Cancer 2013 ·Clinical Cancer Research ·Éric Lévesque, Isabelle Laverdière, Louis Lacombe, Patrick Caron, Mélanie Rouleau, Véronique Turcotte, Bernard Têtu, Yves Fradet, Chantal Guillemette	24
5	Strategies for Biochemical and Pathologic Quality Assurance in a Large Multi-Institutional Biorepository; The Experience of the PROCURE Quebec Prostate Cancer Biobank 2013 ·Biopreservation and Biobanking ·Fadi Brimo, Armen Aprikian, Mathieu Latour, Bernard Têtu, Alexandre A. Doueik, Eleonora Scarlata, Lucie Hamel, Ginette McKercher, Fred Saad, Louis Lacombe, Michel Carmel, Simone Chevalier	14
6	Le réseau de télépathologie de l’Est du Québec 2012 ·médecine/sciences ·Bernard Têtu, J.-C. Boulanger, Christine Houde, Jean‐Paul Fortin, Marie‐Pierre Gagnon, Geneviève Roch, Guy Paré, Marie-Claude Trudel, Claude Sicotte	7
7	Green tea for ovarian cancer prevention and treatment: A systematic review of the in vitro, in vivo and epidemiological studies 2012 ·Gynecologic Oncology ·Dominique Trudel, David P. Labbé, Isabelle Bairati, Vincent Fradet, Laurent Bazinet, Bernard Têtu	37
8	Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer 2011 ·Molecular Oncology ·(unknown), Magdalena Bachvarova, Marie Plante, Jean‐Pierre Grégoire, Marie‐Claude Renaud, Karim Ghani, Bernard Têtu, Isabelle Bairati, Dimcho Bachvarov	33
9	Matrix metalloproteinase 9 is associated with Gleason score in prostate cancer but not with prognosis 2010 ·Human Pathology ·Dominique Trudel, Yves Fradet, François Meyer, Bernard Têtu	22
10	Identification of PCA3 (DD3) in prostatic carcinoma by in situ hybridization 2007 ·Modern Pathology ·Ion Popa, Yves Fradet, Geneviève Beaudry, Hélène Hovington, (unknown), Bernard Têtu	50
11	Gene expression patterns of chemoresistant and chemosensitive serous epithelial ovarian tumors with possible predictive value in response to initial chemotherapy 2006 ·International Journal of Oncology ·Dimcho Bachvarov, Sylvain L’Espérance, Ion Popa, Magdalena Bachvarova, Marie Plante, Bernard Têtu	34
12	Antioxidant vitamins supplementation and mortality: A randomized trial in head and neck cancer patients 2006 ·International Journal of Cancer ·Isabelle Bairati, François Meyer, (unknown), Michel Gélinas, A. Fortin, Abdenour Nabid, François Brochet, Bernard Têtu	133
13	Prostate cancer: MMP2, MMP9, MMP14, TIMP2 and disease-free survival 2004 ·Cancer Research ·Dominique Trudel, Yves Fradet, François Meyer, François Harel, Bernard Têtu	2
14	p53 and c-erbB-2 as markers of resistance to adjuvant chemotherapy in breast cancer. 1998 ·PubMed ·Bernard Têtu, Jacques Brisson, V. Planté, Paul‐Marie Bernard	60
15	The Molecular Basis of Turcot's Syndrome breakdown → 1995 ·New England Journal of Medicine ·Stanley R. Hamilton, Bo Liu, Ramon Parsons, Nickolas Papadopoulos, Jin Jen, Steven M. Powell, Anne J. Krush, Theresa Berk, Zane Cohen, Bernard Têtu, Peter C. Burger, Patricia A. Wood, (unknown), Susan V. Booker, Gloria M. Petersen, G. Johan A. Offerhaus, Anne C. Tersmette, Francis M. Giardiello, Bert Vogelstein, Kenneth W. Kinzler	719
16	Blood group antigen expression in bladder tumors: An immunohistochemical study of superficial bladder lesions 1994 ·Journal of Experimental & Clinical Cancer Research ·A. S. Sarkis, Elizabeth Charytonowicz, Carlos Cordon‐Cardo, Yves Fradet, F. Herz, Brian H. Mayall, Victor E. Reuter, (unknown), William R. Fair, Fred Waldman, Patrick Carroll, Karen Chew, Bernard Têtu, Fathinul Fikri Ahmad Saad, Jeff Gauthier, L. G. Koss, Bogdan Czerniak	5
17	High levels of P-glycoprotein detected in isolated brain capillaries 1993 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Lucie Jetté, Bernard Têtu, Richard Béliveau	96
18	Effect of Combination Endocrine Therapy (LHRH Agonist and Flutamide) on Normal Prostate and Prostatic Adenocarcinoma 1991 ·The American Journal of Surgical Pathology ·Bernard Têtu, John R. Srigley, (unknown), André Dupont, Gérard Monfette, Sylvie Pinault, Fernand Labrie	93
19	Sertoli-Leydig cell tumor of the ovary with alpha-fetoprotein production. 1986 ·PubMed ·Bernard Têtu, Nelson G. Ordóǹez, (unknown)	14
20	[Renin-secreting renal tumor. Apropos of a case with an ultrastructural and immunohistochemical study]. 1984 ·PubMed ·Bernard Têtu, V. Totović, (unknown), (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact